User:Elizabeth Perkins: Difference between revisions
No edit summary |
|||
Line 76: | Line 76: | ||
Links to Archived Seminars: | |||
http:// | October 18, 2011 | ||
Ranadip Pal, PhD | |||
“Modeling Cancer Pathways: How Mathematical Modeling can Assist in Selecting & Predicting the Effectiveness of Targeted Drug Combinations” | |||
http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/seminar101811.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%20Oct.%2018%2C%202011 | |||
October 4, 2011 | |||
Paul T. Spellman, PhD | |||
“Systems Approaches to Understanding Cancer Biology & Treatment” | |||
http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/seminar100411.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%20Oct.%204%2C%202011 | |||
June 21, 2011 | |||
William Stratford May, MD, PhD | |||
“TNK1/KOS1: A Protein Tyrosine Kinase with a Tumor Suppressor Function” | |||
http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/may062111.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%2C%20June%2021.%202011 | |||
June 14, 2011 | |||
James Ford, MD | |||
“Targeting DNA Repair for the Treatment and Prevention of Triple-Negative Breast Cancer” | |||
http://www.ohsu.edu/edcomm/flash/flash_player.php?params=4%60/res/kci/ford061411.flv%60vod%60s&width=640&height=480&sec=true&title=Knight%20Cancer%20Institute%20Seminar%20Series%2C%20June%2014%2C%202011 |
Revision as of 09:12, 21 October 2011
Knight Cancer Institute Seminar Series
- Charles Keller, MD Pediatric Cancer Biology Program
- c/o Elizabeth Perkins, Administrative Coordinator
- Oregon Health & Science University
- Pape'Family Pediatric Research Institute
- Mail Code: L321
- 3181 SW Sam Jackson Park Road
- Portland, OR 97239
- 503-494-9962
- perkinel@ohsu.edu
http://portal.ohsu.edu/blogs/researchnews/
Objectives of the Knight Cancer Institute Seminar Series
The 2nd Annual Knight Cancer Institute Seminar series, co-sponsored by the Pediatric Cancer Biology program and the Knight Cancer Institute, will have a strong presence of childhood cancer basic and translational research topics presented by leading extramural scientists.
4:00pm TUESDAYS - OHSU MAIN HOSPITAL 8TH FLOOR CONFERENCE ROOM 8B60
-Schedule Subject to Chage-
October 4, 2011
Paul T. Spellman, PhD - OHSU
October 18, 2011
Ranadip Pal, PhD - Texas Tech
November 15, 2011
Alexander A. Gimelbrant, PhD - Dana Farber Cancer Institute
December 13, 2011
Bradley Bruce Olwin, PhD - Colorado University - Boulder
January 31, 2012
Mark Kieran, MD, PhD - Dana Farber Cancer Institute
February 21, 2012
Doug Yee, MD - Masonic Center University of Minnesota
February 28, 2012
Gordon B. Mills, MD, PhD - MD Anderson Cancer Center
March 13, 2012
Jeffrey M. Rosen, PhD - Baylor College of Medicine
April 17, 2012*
Elizabeth Blackburn, PhD - University of California San Francisco
April 24, 2012
Thomas A. Rando, MD, PhD - Stanford University School of Medicine
May 8, 2012
David M. Langenau, PhD - Massachusetts General Hospital
- Location Changed to Vollum M1441
Links to Archived Seminars:
October 18, 2011 Ranadip Pal, PhD “Modeling Cancer Pathways: How Mathematical Modeling can Assist in Selecting & Predicting the Effectiveness of Targeted Drug Combinations”
October 4, 2011 Paul T. Spellman, PhD “Systems Approaches to Understanding Cancer Biology & Treatment”
June 21, 2011 William Stratford May, MD, PhD “TNK1/KOS1: A Protein Tyrosine Kinase with a Tumor Suppressor Function”
June 14, 2011 James Ford, MD “Targeting DNA Repair for the Treatment and Prevention of Triple-Negative Breast Cancer”